CONTACT INFORMATION http://www.loyola.org
Scott Smith
M.D.,Ph.D., FACP
  • Associate Professor
  • Hematology/Oncology
Specialties
Leukemia, Non-Hodgkin's Lymphoma, Refractory Lymphoma, Relapsed Lymphoma, Bone Marrow Disorders
Board Certifications
  • Hematology - Subspecialty Cert: AM Board of Internal Medicine
  • Medical Oncology - Subspecialty Cert: AM Board of Internal Medicine
Publications

Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual diseaseSobol,U.; Rodriguez,T.; Smith,S.; Go,A.; Vimr,R.; Parthasarathy,M.; Guo,R.; Stiff,P.Leukemia & lymphoma 2014 ;55(6):1281-1287

High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemiaO'Brien,S.; Schiller,G.; Lister,J.; Damon,L.; Goldberg,S.; Aulitzky,W.; Ben-Yehuda,D.; Stock,W.; Coutre,S.; Douer,D.; Heffner,L. T.; Larson,M.; Seiter,K.; Smith,S.; Assouline,S.; Kuriakose,P.; Maness,L.; Nagler,A.; Rowe,J.; Schaich,M.; Shpilberg,O.; Yee,K.; Schmieder,G.; Silverman,J. A.; Thomas,D.; Deitcher,S. R.; Kantarjian,H.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 ;31(6):676-683

Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimensStiff,P. J.; Fox-Geiman,M. P.; Kiley,K.; Rychlik,K.; Parthasarathy,M.; Fletcher-Gonzalez,D.; Porter,N.; Go,A.; Smith,S. E.; Rodriguez,T. E.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013 ;19(1):49-55.e1

Brentuximab vedotin does not cause clinically relevant QTc interval prolongation in patients with CD30-positive hematologic malignanciesHan,T. H.; Chen,R.; Advani,R.; Berryman,R. B.; Smith,S. E.; Forero-Torres,A.; Rosenblatt,J. D.; Smith,M. R.; Zain,J.; Hunder,N. N.; Engert,A.CANCER CHEMOTHERAPY AND PHARMACOLOGY 2013 ;72(1):241-249

Spontaneous regression of follicular dendritic cell sarcomaCaces,D. B.; Daniel,S.; Paredes-Tejada,J. M.; Smith,S.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 ;30(3):e24-6

TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomesChoi,S. W.; Stiff,P.; Cooke,K.; Ferrara,J. L.; Braun,T.; Kitko,C.; Reddy,P.; Yanik,G.; Mineishi,S.; Paczesny,S.; Hanauer,D.; Pawarode,A.; Peres,E.; Rodriguez,T.; Smith,S.; Levine,J. E.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012 ;18(10):1525-1532

A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndromeRaza,A.; Galili,N.; Smith,S. E.; Godwin,J.; Boccia,R. V.; Myint,H.; Mahadevan,D.; Mulford,D.; Rarick,M.; Brown,G. L.; Schaar,D.; Faderl,S.; Komrokji,R. S.; List,A. F.; Sekeres,M.Cancer 2012 ;118(8):2138-2147

Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation.Gerds,A.; Fox-Geiman,M.; Dawravoo,K.; Rodriguez,T.; Toor,A.; Smith,S.; Kiley,K.; Fletcher-Gonzalez,D.; Hicks,C.; Stiff,P.Biology of Blood & Marrow Transplantation 2010 ;16(5):678-685

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortiumSmith,S. M.; van Besien,K.; Karrison,T.; Dancey,J.; McLaughlin,P.; Younes,A.; Smith,S.; Stiff,P.; Lester,E.; Modi,S.; Doyle,L. A.; Vokes,E. E.; Pro,B.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(31):4740-4746

The impact of pharmacotherapy on depression and quality of life in patients undergoing a bone marrow transplant (BMT).Mumby,P. B.; Garcia,C.; Trivedi-Purohit,R.; Gourvitz,R.; Rychlik,K.; Rodriguez,T.; Smith,S. E.; Toor,A. A.; Rao,M.; Stiff,P. J.ASCO Meeting Abstracts 2010 ;28(15_suppl):9132

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern eraEvens,A. M.; David,K. A.; Helenowski,I.; Nelson,B.; Kaufman,D.; Kircher,S. M.; Gimelfarb,A.; Hattersley,E.; Mauro,L. A.; Jovanovic,B.; Chadburn,A.; Stiff,P.; Winter,J. N.; Mehta,J.; Van Besien,K.; Gregory,S.; Gordon,L. I.; Shammo,J. M.; Smith,S. E.; Smith,S. M.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(6):1038-1046

Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantationGerds,A.; Fox-Geiman,M.; Dawravoo,K.; Rodriguez,T.; Toor,A.; Smith,S.; Kiley,K.; Fletcher-Gonzalez,D.; Hicks,C.; Stiff,P.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010 ;16(5):678-685

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndromeRaza,A.; Galili,N.; Smith,S.; Godwin,J.; Lancet,J.; Melchert,M.; Jones,M.; Keck,J. G.; Meng,L.; Brown,G. L.; List,A.Blood 2009 ;113(26):6533-6540

The Curriculum for the Hospitalized Aging Medical Patient program: a collaborative faculty development program for hospitalists, general internists, and geriatricians.Podrazik,P. M.; Levine,S.; Smith,S.; Scott,D.; Dubeau,C. E.; Baron,A.; Whelan,C.; Johnson,J.; Cook,S.; Arora,V.; Meltzer,D.; Sachs,G.Journal of Hospital Medicine (Online) 2008 ;3(5):384-393

Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCTToor,A.; Rodriguez,T.; Bauml,M.; Mathews,H.; Shanti,S.; Senitzer,D.; Kini,A.; Norton,J.; Parthasarathy,M.; Mohideen,N.; Petrowsky,C.; Bonilla,B.; Smith,S.; Stiff,P.Bone marrow transplantation 2008 ;42(11):723-731

Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trialNand,S.; Godwin,J.; Smith,S.; Barton,K.; Michaelis,L.; Alkan,S.; Veerappan,R.; Rychlik,K.; Germano,E.; Stiff,P.Leukemia & lymphoma 2008 ;49(11):2141-2147

A single-institution experience with the AneuRx Stent Graft for endovascular repair of abdominal aortic aneurysm.Smith,S.; Mountcastle,S.; Burridge,A.; Dodson,T. F.; Salam,A. A.; Kasirajan,K.; Milner,R.; Veeraswamy,R.; Chaikof,E. L.Annals of Vascular Surgery 2008 ;22(2):221-226

Sonographic appearance of ruptured ovarian cyst in the neonatal period.Gallagher,T. A.; Lim-Dunham,J. E.; Vade,A.; Smith,S.; Salhadar,A.; Ward,K. A.Journal of Clinical Ultrasound 2008 ;36(1):53-55

The administration of polymerized human hemoglobin (Pyridoxylated) to a Jehovah's Witness after submyeloablative stem cell transplantation complicated by delayed graft failureSmith,S. E.; Toor,A.; Rodriguez,T.; Stiff,P.Comprehensive therapy 2006 ;32(3):172-175

Acute myeloid leukemia in the older patientGodwin,J. E.; Smith,S. E.Critical Reviews in Oncology-Hematology 2003 ;48(Suppl):S17-26

Education
Medical School
  • Wayne State University School of Medicine
Residency
  • Loyola University Medical Center, Internal Medicine: General
Fellowship
  • Loyola University Medical Center, Hematology/Oncology
Interests
  • Fly Fishing
  • Mountain Biking
  • Hiking
  • Reading
  • Golf